Albireo Pharma, Inc. (ALBO) Q1 2021 Earnings Call Transcript
ALBO earnings call for the period ending March 31, 2021.
Albireo Pharma, Inc.(ALBO)
Nasdaq Capital Market (Nasdaq)
ALBO
$29.72
$0.82
2.8%
Price as of May 11, 2021, 4:00 p.m. ET
View Interactive ALBO Charts
A specialty pharmaceutical company, which focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes and osteoporosis.
Interactive Chart
News & Analysis: Albireo Pharma, Inc.
Albireo Pharma, Inc. (ALBO) Q4 2020 Earnings Call Transcript
ALBO earnings call for the period ending December 31, 2020.
Why Albireo Pharma Stock Is Skyrocketing Today
The company reported positive data from a clinical trial.
Albireo Pharma, Inc. (ALBO) Q2 2020 Earnings Call Transcript
ALBO earnings call for the period ending June 30, 2020.
Albireo Pharma, Inc. (ALBO) Q1 2020 Earnings Call Transcript
ALBO earnings call for the period ending March 31, 2020.
Albireo Pharma, Inc. (ALBO) Q4 2019 Earnings Call Transcript
ALBO earnings call for the period ending December 31, 2019.
Albireo Pharma, Inc. (ALBO) Q3 2019 Earnings Call Transcript
ALBO earnings call for the period ending September 30, 2019.
Albireo Pharma, Inc. (ALBO) Q2 2019 Earnings Call Transcript
ALBO earnings call for the period ending June 30, 2019.
Albireo Pharma, Inc. (ALBO) Q1 2019 Earnings Call Transcript
ALBO earnings call for the period ending March 31, 2019.
Albireo Pharma, Inc. (ALBO) Q4 2018 Earnings Conference Call Transcript
ALBO earnings call for the period ending December 31, 2018.
